c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper

Children frequently respond differently to therapies compared to adults. Differences also exist between paediatric age groups for pharmacokinetics and pharmacodynamics in both efficacy and safety. Paediatric pharmacovigilance requires an understanding of the unique aspects of children with regard to...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurich, Beate, Apele‐Freimane, Dina, Banaschewski, Tobias, Chouchana, Laurent, Day, Simon, Kaguelidou, Florentia, Kelly, Lauren E., Kindblom, Jenny M., Neubert, Antje, Wong, Ian C. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788092/
https://www.ncbi.nlm.nih.gov/pubmed/34699077
http://dx.doi.org/10.1111/bcp.15119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788092/
https://www.ncbi.nlm.nih.gov/pubmed/34699077
http://dx.doi.org/10.1111/bcp.15119

Ejemplares similares